Management of Digestive Haemorrhaging In CHRU of Brest During 2009 and 2014

University Hospital, Brest272 enrolled

Overview

Gastro intestinal (GI) bleeding is relatively frequent and may lead to intensive care unit admission. Although a restrictive strategy for red blood cell transfusion is supported by a large randomized controlled trial literature, less is known about the impact of transfusion strategy of other blood components and administration of anti fibrinolytic on clinical outcomes. This study aims to identify parameters that may be associated with the risk of further bleeding in patients admitted to ICU for GI bleeding.

Study Type

OBSERVATIONAL

Enrollment

272

Conditions

Gastro Intestinal Bleeding

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with Gastro Intestinal Bleeding admitted to either medical or surgical intensive care unit Exclusion Criteria: * patients retrieved from another hospital * age \< 18 years consent withdrawal

Locations (1)

CHRU de Brest

Brest, France

Outcomes

Primary Outcomes

Bleeding

Bleeding persistance or recidive requiring an intervention or a scope

Time frame: within a week

Secondary Outcomes

mortality

hospital mortality

Time frame: during hospitalisation (28 days)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.